Cadence Bank Abbott Laboratories Transaction History

Cadence Bank

$1.37 Billion
Q1 2024

A detailed history of Cadence Bank transactions in Abbott Laboratories stock. As of the latest transaction made, Cadence Bank holds 45,023 shares of ABT stock, worth $4.65 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

45,023

Previous 45,154 0.29%

Holding current value

$4.65 Million

Previous $4.97 Million 2.96%

% of portfolio

0.37%

Previous 0.4%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$109.52 - $120.96 $14,347 - $15,845	-131 Reduced 0.29%	45,023 $5.12 Million
Q4 2023 Feb 13, 2024	SELL	$90.19 - $110.4 $53,753 - $65,798	-596 Reduced 1.3%	45,154 $4.97 Million
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $23,595 - $28,311	-247 Reduced 0.54%	45,750 $4.43 Million
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $104,508 - $116,444	1,037 Added 2.31%	45,997 $5.01 Million
Q1 2023 May 12, 2023	BUY	$96.86 - $114.01 $51,238 - $60,311	529 Added 1.19%	44,960 $4.55 Million

Q4 2022 Feb 13, 2023	SELL	$95.06 - $111.52 $36,978 - $43,381	-389 Reduced 0.87%	44,431 $4.88 Million
Q3 2022 Nov 10, 2022	BUY	$96.76 - $112.03 $3.51 Million - $4.07 Million	36,292 Added 425.56%	44,820 $4.34 Million
Q2 2022 Aug 12, 2022	SELL	$102.07 - $123.37 $33,172 - $40,095	-325 Reduced 3.67%	8,528 $927,000
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $452,659 - $551,988	3,970 Added 81.3%	8,853 $1.05 Million
Q4 2021 Feb 11, 2022	SELL	$115.53 - $141.46 $1,848 - $2,263	-16 Reduced 0.33%	4,883 $687,000
Q3 2021 Nov 10, 2021	BUY	$116.66 - $129.06 $37,914 - $41,944	325 Added 7.11%	4,899 $579,000
Q1 2021 May 11, 2021	SELL	$108.84 - $128.23 $553,016 - $651,536	-5,081 Reduced 52.63%	4,574 $548,000
Q4 2020 Feb 04, 2021	BUY	$105.0 - $114.42 $525,000 - $572,100	5,000 Added 107.41%	9,655 $1.06 Million
Q2 2020 Jul 27, 2020	SELL	$76.57 - $98.0 $612 - $784	-8 Reduced 0.17%	4,655 $426,000
Q1 2020 Apr 30, 2020	BUY	$62.82 - $91.86 $9,108 - $13,319	145 Added 3.21%	4,663 $368,000
Q4 2019 Feb 04, 2020	SELL	$78.51 - $87.4 $31,404 - $34,960	-400 Reduced 8.13%	4,518 $392,000
Q3 2019 Nov 06, 2019	SELL	$81.84 - $88.74 $15,385 - $16,683	-188 Reduced 3.68%	4,918 $411,000
Q2 2019 Jul 30, 2019	BUY	$72.88 - $85.0 $4,882 - $5,695	67 Added 1.33%	5,106 $429,000
Q4 2018 Feb 07, 2019	BUY	$65.56 - $74.27 $27,272 - $30,896	416 Added 9.0%	5,039 $364,000
Q3 2018 Oct 25, 2018	SELL	$60.81 - $73.36 $2,918 - $3,521	-48 Reduced 1.03%	4,623 $339,000
Q2 2018 Aug 09, 2018	SELL	$57.57 - $63.54 $123,660 - $136,483	-2,148 Reduced 31.5%	4,671 $285,000
Q1 2018 May 03, 2018	SELL	$56.27 - $63.62 $3,094 - $3,499	-55 Reduced 0.8%	6,819 $409,000
Q4 2017 Feb 12, 2018	BUY	$53.68 - $57.47 $368,996 - $395,048	6,874	6,874 $0

Others Institutions Holding ABT

# of Institutions

3,129

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $181B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cadence Bank, based on Form 13F filings with the SEC.

News

Stay updated on Cadence Bank with notifications on news.

Account